Trucheck™ FemmeSafe is a blood test that can detect cancer in women
Trucheck™ FemmeSafe is a blood-based Multi-Cancer screening test designed for asymptomatic women. This innovative test employs Circulating Tumor Cells (CTCs) for the early detection of breast, ovarian, cervical and uterine (endometrial) cancers in women. These cancers collectively account for 59% of all cancer-related deaths and 51% of the most common incident cancers among women in Ireland.
Criteria to take the test:
- Women above 40 years of age, who have never been diagnosed with any cancer.
- Totally asymptomatic at present
- No prior history of diagnosis or treatment of any cancer
- No clinical or radiological suspicion of cancer at present